ACN vs G: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: G is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and G share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and G exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

Genpact Limited was spun out of GE's Indian back-office operations in 2005 and has spent two decades running processes that its clients would rather not run themselves: accounts payable, order-to-cash, procurement, claims handling, anti-money-laundering alert review, supply-chain planning and customer service. Revenue comes from long-duration contracts with roughly 800 clients concentrated in banking and capital markets, insurance, consumer goods, life sciences and high-tech manufacturing, delivered by a workforce of around 125,000 people spread across India, the Philippines, Eastern Europe and Latin America. Trailing twelve-month revenue is about ~$5.25 billion, and the business is structurally profitable, with gross margin near ~36.5% and a consistent record of converting earnings into free cash flow, dividends and buybacks.

Full G guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• G drivers: Advanced Technology Solutions mix shift; Agent-shaped repackaging of existing service lines.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For G, the central risk is that agentic AI compresses the price of the work Genpact performs faster than volumes or new offerings replace it, and analysts have flagged exactly this: ATS may not fully offset a slowing legacy base.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; G if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and G guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

G. Genpact trades at roughly ~1.1x trailing revenue and high-single-digit to low-double-digit earnings multiples, near the bottom of the IT and business-services group and well below Infosys or Accenture on the same basis. That gap exists because investors are discounting the durability of headcount-linked outsourcing revenue in an AI environment, not because current results are weak: full-year 2026 guidance calls for revenue growth of at least ~7% with Q3 adjusted EPS of roughly ~$1.04 to ~$1.05. The valuation debate is therefore about terminal demand rather than near-term execution.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); G shows revenue (ttm) ~$5.25B, market cap ~$5.69B, q2 2026 net revenue ~$1.34B, up ~7.1% year over year, q2 2026 adjusted eps ~$1.00, up ~13.6%.

ACN and G are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and G exposure against your real portfolio. It is not an investment adviser.